These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1359 related items for PubMed ID: 15955463

  • 1. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.
    Yanni AE, Perrea DN, Yatzidis HA.
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463
    [Abstract] [Full Text] [Related]

  • 2. Appreciation of concentration of lipoproteins and apolipoproteins in serum of male rats under the influence of diet change composition and its supplementation with group B vitamins.
    Goluch-Koniuszy Z, Wierzbicka A.
    Acta Sci Pol Technol Aliment; 2011 Jun; 10(1):113-21. PubMed ID: 22232533
    [Abstract] [Full Text] [Related]

  • 3. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study.
    Holme I, Høstmark AT, Anderssen SA.
    J Intern Med; 2007 Aug; 262(2):235-43. PubMed ID: 17645591
    [Abstract] [Full Text] [Related]

  • 4. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
    Matthan NR, Welty FK, Barrett PH, Harausz C, Dolnikowski GG, Parks JS, Eckel RH, Schaefer EJ, Lichtenstein AH.
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1092-7. PubMed ID: 15087307
    [Abstract] [Full Text] [Related]

  • 5. Dietary L-aspartate and L-glutamate inhibit fatty streak initiation in cholesterol-fed rabbit.
    Yanni AE, Yatzidis HA, Kavantzas NG, Agapitos EV, Perrea DN, Karayannacos PE.
    Nutr Metab Cardiovasc Dis; 2003 Apr; 13(2):80-6. PubMed ID: 12929620
    [Abstract] [Full Text] [Related]

  • 6. Oral supplementation with L-aspartate and L-glutamate inhibits atherogenesis and fatty liver disease in cholesterol-fed rabbit.
    Yanni AE, Agrogiannis G, Nomikos T, Fragopoulou E, Pantopoulou A, Antonopoulou S, Perrea D.
    Amino Acids; 2010 May; 38(5):1323-31. PubMed ID: 19701712
    [Abstract] [Full Text] [Related]

  • 7. Serum trypsin-like activity in chronic alcoholized men: possible relationship with lipids, apoA-1 and apoB lipoproteins.
    Joly JP, Sesboüe R, Hillemand B, Martin JP.
    Alcohol Alcohol; 1992 Sep; 27(5):563-9. PubMed ID: 1476559
    [Abstract] [Full Text] [Related]

  • 8. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR, Jalbert SM, Lamon-Fava S, Dolnikowski GG, Welty FK, Barrett HR, Schaefer EJ, Lichtenstein AH.
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
    [Abstract] [Full Text] [Related]

  • 9. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [Abstract] [Full Text] [Related]

  • 10. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
    Sniderman AD, Jungner I, Holme I, Aastveit A, Walldius G.
    J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
    [Abstract] [Full Text] [Related]

  • 11. [Relationship between gene polymorphism at the apolipoprotein E locus and serum lipid profile in urban children of school age in Beijing].
    Zhu W, Feng N, Wang Y.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):297-300. PubMed ID: 11769625
    [Abstract] [Full Text] [Related]

  • 12. Anti-atherogenic effects of seabuckthorn (Hippophaea rhamnoides) seed oil.
    Basu M, Prasad R, Jayamurthy P, Pal K, Arumughan C, Sawhney RC.
    Phytomedicine; 2007 Nov; 14(11):770-7. PubMed ID: 17498939
    [Abstract] [Full Text] [Related]

  • 13. Lipid and lipoprotein profiles relate to peak aerobic power in spinal cord injured men.
    Bostom AG, Toner MM, McArdle WD, Montelione T, Brown CD, Stein RA.
    Med Sci Sports Exerc; 1991 Apr; 23(4):409-14. PubMed ID: 2056897
    [Abstract] [Full Text] [Related]

  • 14. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet.
    Schulpis KH, Karakonstantakis T, Bartzeliotou A, Karikas GA, Papassotiriou I.
    Clin Nutr; 2004 Jun; 23(3):401-7. PubMed ID: 15158304
    [Abstract] [Full Text] [Related]

  • 15. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD.
    Clin Chem Lab Med; 2004 Jun; 42(12):1355-63. PubMed ID: 15576296
    [Abstract] [Full Text] [Related]

  • 16. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
    Khadem-Ansari MH, Rasmi Y, Rahimi-Pour A, Jafarzadeh M.
    Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
    [Abstract] [Full Text] [Related]

  • 17. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ, Gansevoort RT, Hillege HJ, Wolffenbuttel BH, Dullaart RP, PREVEND Study Group.
    J Clin Lipidol; 2013 Jun; 7(1):56-64. PubMed ID: 23351584
    [Abstract] [Full Text] [Related]

  • 18. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
    Waysbort J, Regitz G, Chaimowitz D, Tuval M, Nakash I, Brunner D.
    Clin Ther; 1988 Jun; 10(4):358-71. PubMed ID: 2978874
    [Abstract] [Full Text] [Related]

  • 19. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V, Sánchez-Quesada JL, Antón R, Camacho M, Julve J, Escolà-Gil JC, Vila L, Ordóñez-Llanos J, Blanco-Vaca F.
    Circ Res; 2004 Oct 15; 95(8):789-97. PubMed ID: 15388641
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 68.